A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners(2022)

引用 1|浏览10
暂无评分
摘要
Our extemporaneous oral suspension is an adequate alternative for the commercially (un)available oral suspension in young children. An adequate exposure to aprepitant in children was yielded and the bioavailability of the extemporaneous suspension was comparable to capsules.
更多
查看译文
关键词
Oncology,Pediatrics,Pharmacokinetics,Pharmacology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要